Literature DB >> 31612322

New and enlarging white matter lesions adjacent to the ventricle system and thalamic atrophy are independently associated with lateral ventricular enlargement in multiple sclerosis.

Tim Sinnecker1,2,3, Esther Ruberte3, Sabine Schädelin4, Vera Canova1, Michael Amann3, Yvonne Naegelin1, Iris-Katharina Penner5, Jannis Müller1,2, Jens Kuhle1, Bernhard Décard1, Tobias Derfuss1, Ludwig Kappos1, Cristina Granziera1,2, Jens Wuerfel3, Stefano Magon1,2,3, Özgür Yaldizli6,7,8.   

Abstract

OBJECTIVE: To investigate the association between new or enlarging T2-weighted (w) white matter (WM) lesions adjacent to the ventricle wall, deep grey matter (DGM) atrophy and lateral ventricular enlargement in multiple sclerosis (MS).
METHODS: Patients derived from the Genetic Multiple Sclerosis Associations study. Lateral ventricles and DGM were segmented fully automated at baseline and 5 years follow-up using Automatic Lateral Ventricle delineation (ALVIN) and Multiple Automatically Generated Templates brain segmentation algorithm (MAgeT), respectively. T2w and T1w lesions were manually segmented. To investigate the association between lesion distance to the ventricle wall and the lateral ventricle volume, we parcellated the WM into concentric periventricular bands using FMRIB Software Library. Associations between clinical and MRI parameters were assessed in generalized linear models using generalized estimating equations for repeated measures.
RESULTS: We studied 127 MS patients. Lateral ventricles enlarged on average by 2.4%/year. Patients with new/enlarging T2w WM lesions between baseline and follow-up at 5 years had accelerated lateral ventricular enlargement compared with patients without (p = 0.004). This was true in a multivariable analysis adjusted for age, gender, and whole brain atrophy. When looking at the T2w lesions in different periventricular bands, we found the strongest association between new/enlarging T2w lesions and lateral ventricle enlargement for WM lesions adjacent to the ventricle system (p < 0.001). Moreover, and indepedent of new/enlarging WM lesions, DGM atrophy was associated with ventricular enlargement. In a multivariable analysis, this was driven by thalamic atrophy (p < 0.001).
CONCLUSION: New/enlarging T2w lesions adjacent to the ventricle system and thalamic atrophy are independently associated with lateral ventricular enlargement in MS.

Entities:  

Keywords:  Lateral ventricle volume; MRI; Multiple sclerosis; Periventricular white matter lesion; Thalamic atrophy

Mesh:

Year:  2019        PMID: 31612322     DOI: 10.1007/s00415-019-09565-w

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  29 in total

1.  Quantitative functional measures in MS: what is a reliable change?

Authors:  S R Schwid; A D Goodman; M P McDermott; C F Bever; S D Cook
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

Review 2.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

3.  Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a.

Authors:  T Uher; D Horakova; T Kalincik; N Bergsland; M Tyblova; D P Ramasamy; Z Seidl; M Vaneckova; J Krasensky; E Havrdova; R Zivadinov
Journal:  Eur J Neurol       Date:  2015-04-22       Impact factor: 6.089

4.  Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group.

Authors:  R A Rudick; E Fisher; J C Lee; J Simon; L Jacobs
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

5.  Ventricular enlargement in multiple sclerosis: a comparison of three-dimensional and linear MRI estimates.

Authors:  B Turner; N Ramli; L D Blumhardt; T Jaspan
Journal:  Neuroradiology       Date:  2001-08       Impact factor: 2.804

6.  Connecting white matter injury and thalamic atrophy in clinically isolated syndromes.

Authors:  Roland G Henry; Mason Shieh; Bagrat Amirbekian; SungWon Chung; Darin T Okuda; Daniel Pelletier
Journal:  J Neurol Sci       Date:  2009-04-23       Impact factor: 3.181

7.  Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.

Authors:  Marco Vercellino; Silvia Masera; Marcella Lorenzatti; Cecilia Condello; Aristide Merola; Alessandra Mattioda; Antonella Tribolo; Elisabetta Capello; Giovanni Luigi Mancardi; Roberto Mutani; Maria Teresa Giordana; Paola Cavalla
Journal:  J Neuropathol Exp Neurol       Date:  2009-05       Impact factor: 3.685

8.  Fingolimod's Impact on MRI Brain Volume Measures in Multiple Sclerosis: Results from MS-MRIUS.

Authors:  Robert Zivadinov; Jennie Medin; Nasreen Khan; Jonathan R Korn; Niels Bergsland; Michael G Dwyer; Tanuja Chitnis; Robert T Naismith; Enrique Alvarez; Peter Kinkel; Stanley Cohan; Samuel F Hunter; Diego Silva; Bianca Weinstock-Guttman
Journal:  J Neuroimaging       Date:  2018-05-11       Impact factor: 2.486

Review 9.  Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance.

Authors:  David H Miller; Frederik Barkhof; Joseph A Frank; Geoffrey J M Parker; Alan J Thompson
Journal:  Brain       Date:  2002-08       Impact factor: 13.501

10.  Pathway and network-based analysis of genome-wide association studies in multiple sclerosis.

Authors:  Sergio E Baranzini; Nicholas W Galwey; Joanne Wang; Pouya Khankhanian; Raija Lindberg; Daniel Pelletier; Wen Wu; Bernard M J Uitdehaag; Ludwig Kappos; Chris H Polman; Paul M Matthews; Stephen L Hauser; Rachel A Gibson; Jorge R Oksenberg; Michael R Barnes
Journal:  Hum Mol Genet       Date:  2009-03-13       Impact factor: 6.150

View more
  4 in total

1.  Periventricular gradient of T1 tissue alterations in multiple sclerosis.

Authors:  Manuela Vaneckova; Gian Franco Piredda; Michaela Andelova; Jan Krasensky; Tomas Uher; Barbora Srpova; Eva Kubala Havrdova; Karolina Vodehnalova; Dana Horakova; Tom Hilbert; Bénédicte Maréchal; Mário João Fartaria; Veronica Ravano; Tobias Kober
Journal:  Neuroimage Clin       Date:  2022-04-16       Impact factor: 4.891

2.  Contribution of white matter hyperintensities to ventricular enlargement in older adults.

Authors:  Angela C C Jochems; Susana Muñoz Maniega; Maria Del C Valdés Hernández; Gayle Barclay; Devasuda Anblagan; Lucia Ballerini; Rozanna Meijboom; Stewart Wiseman; Adele M Taylor; Janie Corley; Francesca M Chappell; Ellen V Backhouse; Michael S Stringer; David Alexander Dickie; Mark E Bastin; Ian J Deary; Simon R Cox; Joanna M Wardlaw
Journal:  Neuroimage Clin       Date:  2022-04-26       Impact factor: 4.891

3.  Decreased Brain Ventricular Volume in Psychiatric Inpatients with Serotonin Reuptake Inhibitor Treatment.

Authors:  P K Bolin; S N Gosnell; K Brandel-Ankrapp; N Srinivasan; A Castellanos; R Salas
Journal:  Chronic Stress (Thousand Oaks)       Date:  2022-07-14

4.  Longitudinal changes of deep gray matter shape in multiple sclerosis.

Authors:  Charidimos Tsagkas; Emanuel Geiter; Laura Gaetano; Yvonne Naegelin; Michael Amann; Katrin Parmar; Athina Papadopoulou; Jens Wuerfel; Ludwig Kappos; Till Sprenger; Cristina Granziera; M Mallar Chakravarty; Stefano Magon
Journal:  Neuroimage Clin       Date:  2022-07-29       Impact factor: 4.891

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.